Works matching IS 03065251 AND DT 2023 AND VI 89 AND IP 7

Results: 44

Issue Highlights.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1913, doi. 10.1111/bcp.15812

By:

Cremers, Serge

Publication type:

Article

The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2020, doi. 10.1111/bcp.15761

By:

Giunchi, Valentina;
Fusaroli, Michele;
Linder, Elkanah;
Villén, Johanna;
Wettermark, Björn;
Nekoro, Marmar;
Raschi, Emanuel;
Lunghi, Carlotta;
Poluzzi, Elisabetta

Publication type:

Article

Polypharmacy and associated cumulative anticholinergic burden are important predictors of falls risk.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2332, doi. 10.1111/bcp.15753

By:

Wong, Ho Lun;
Mandal, Amit K. J.;
Weaver, Claire;
Chauhan, Rahul;
Missouris, Constantinos G.

Publication type:

Article

Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2039, doi. 10.1111/bcp.15751

By:

Zhao, Sharon;
Hwang, Austin;
Miller, Corinne;
Lio, Peter

Publication type:

Article

Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2028, doi. 10.1111/bcp.15748

By:

Branford, David;
Sun, James J.;
Burrows, Lisa;
Shankar, Rohit

Publication type:

Article

Ensovibep, a SARS‐CoV‐2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first‐in‐human, ascending single‐dose Phase 1 study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2295, doi. 10.1111/bcp.15747

By:

Stojcheva, Nina;
Gladman, Stacy;
Soergel, Marianne;
Zitt, Christof;
Drake, Roxana;
Lockett, Tony;
Marchand, Carine;
Fustier, Pierre;
Stavropoulou, Vaia;
Fernandez, Elena;
Pettigiani, Nathana Lopes;
Watkins, Kate;
Puri, Adeep;
Watson, Randall;
Legenne, Philippe;
Stumpp, Michael T.;
Boyce, Malcolm

Publication type:

Article

Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2304, doi. 10.1111/bcp.15743

By:

Haefliger, David;
Marzolini, Catia;
Lamoth, Frederic;
Pabst, Thomas;
Buclin, Thierry;
Livio, Francoise

Publication type:

Article

Physiology‐based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P‐glycoprotein induction and concurrent inhibition.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2329, doi. 10.1111/bcp.15740

By:

Theile, Dirk;
Nilles, Julie;
Meid, Andreas D.

Publication type:

Article

Medication adherence research comes of age.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1914, doi. 10.1111/bcp.15722

By:

Wright, Daniel F. B.;
Sinnappah, Klarissa A.;
Hughes, Dyfrig A.

Publication type:

Article

Prescribing of low‐dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2263, doi. 10.1111/bcp.15708

By:

Hunt, Nicholas B.;
Pajouheshnia, Romin;
Salih, Allan;
van Doorn, Sander;
Souverein, Patrick C.;
Bazelier, Marloes T.;
Klungel, Olaf H.;
Gardarsdottir, Helga

Publication type:

Article

Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2246, doi. 10.1111/bcp.15706

By:

Smith, Robert Løvsletten;
Molden, Espen;
Bernard, Jean‐Paul

Publication type:

Article

Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2283, doi. 10.1111/bcp.15702

By:

Puisset, Florent;
Le Louedec, Félicien;
Dalenc, Florence;
Verguet, Lorène;
De Maio, Eleonora;
Lacaze, Jean Louis;
Montastruc, Marion;
Ung, Mony;
Vinson, Camille;
Perriat, Sophie;
Pacher, Sandrine;
Chatelut, Etienne;
Koning, Mélanie White

Publication type:

Article

Cannabidiol–drug interaction in cancer patients: A retrospective study in a real‐life setting.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2322, doi. 10.1111/bcp.15701

By:

Guedon, Marie;
Le Bozec, Antoine;
Brugel, Mathias;
Clarenne, Justine;
Carlier, Claire;
Perrier, Marine;
Laurent, Maëliss;
Hettler, Dominique;
Mongaret, Céline;
Bouché, Olivier;
Slimano, Florian

Publication type:

Article

Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2272, doi. 10.1111/bcp.15700

By:

Kuchimanchi, Mita;
Dabrowski, Christine;
Lu, Sharon;
Melhem, Murad

Publication type:

Article

Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2236, doi. 10.1111/bcp.15699

By:

Zhang, Ying;
Johnson, Mark;
Joshi, Samit;
Yazdani, Parto;
Zhan, Joyce;
Wen, Bo;
Bainbridge, Veronica;
Gartland, Martin;
Lataillade, Max

Publication type:

Article

Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2224, doi. 10.1111/bcp.15698

By:

Mur, Jure;
Marioni, Riccardo E.;
Russ, Tom C.;
Muniz‐Terrera, Graciela;
Cox, Simon R.

Publication type:

Article

Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2254, doi. 10.1111/bcp.15697

By:

Severino, Nicolas;
Urzúa, Soledad;
Ibacache, Mauricio;
Paulos, Claudio;
Cortínez, Luis;
Toso, Alberto;
Leguizamon, Liliana;
Inojosa, Rocío;
Maccioni, Andrea;
Meza, Sebastián;
García, Andrés;
Ramírez, Marcelo;
Von Mentlen, Catalina;
Ceballos, Javiera;
Paredes, Noemí

Publication type:

Article

Derivation and validation of a risk prediction score for nonsteroidal anti‐inflammatory drug‐related serious gastrointestinal complications in the elderly.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2216, doi. 10.1111/bcp.15696

By:

Lee, Suhyun;
Heo, Kyu‐Nam;
Lee, Mee Yeon;
Ah, Young‐Mi;
Shin, Jaekyu;
Lee, Ju‐Yeun

Publication type:

Article

Evaluation of the effect of ritlecitinib on the pharmacokinetics of caffeine in healthy participants.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2208, doi. 10.1111/bcp.15695

By:

Liu, Jian;
Solan, Rohit;
Wolk, Robert;
Plotka, Anna;
O'Gorman, Melissa T.;
Winton, Jennifer A.;
Kaplan, Julia;
Purohit, Vivek S.

Publication type:

Article

Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance database.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2201, doi. 10.1111/bcp.15693

By:

Montastruc, Jean‐Louis;
Tessier, Samuel;
Bura‐Riviere, Alessandra

Publication type:

Article

Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2316, doi. 10.1111/bcp.15692

By:

Roughley, Matthew;
Mena, Carlos;
Howard, Robert;
Reeves, Suzanne;
Bertrand, Julie

Publication type:

Article

Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2179, doi. 10.1111/bcp.15688

By:

Ehlers, Thomas S.;
van der Horst, Jennifer;
Møller, Sophie;
Piil, Peter K.;
Gliemann, Lasse;
Aalkjær, Christian;
Jepps, Thomas A.;
Hellsten, Ylva

Publication type:

Article

Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: A retrospective cohort study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2168, doi. 10.1111/bcp.15687

By:

Ota, Ryosuke;
Hata, Takeo;
Hirata, Atsushi;
Hamada, Takeshi;
Nishihara, Masami;
Neo, Masashi;
Katsumata, Takahiro

Publication type:

Article

Question‐based development of high‐risk medical devices: A proposal for a structured design and review process.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2144, doi. 10.1111/bcp.15685

By:

White, Nicholas A.;
Oude Vrielink, Timo J. C.;
van der Bogt, Koen E. A.;
Cohen, Adam F.;
Rotmans, Joris I.;
Horeman, Tim

Publication type:

Article

Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2309, doi. 10.1111/bcp.15684

By:

Lehtisalo, Minna;
Kiander, Wilma;
Filppula, Anne M.;
Deng, Feng;
Kidron, Heidi;
Korhonen, Mari;
Sinkko, Johanna;
Koivula, Kimmo;
Niemi, Mikko

Publication type:

Article

Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two‐drug regimen in SWORD‐1/‐2 phase 3 studies.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2190, doi. 10.1111/bcp.15683

By:

Mehta, Rashmi;
Lagishetty, Chakradhar V.;
Angelis, Konstantinos;
Aylott, Alicia;
Kahl, Lesley;
Blair, Libby;
Matthews, Jessica;
Wynne, Brian;
Crauwels, Herta;
Underwood, Mark;
Adkison, Kimberly K.

Publication type:

Article

BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2131, doi. 10.1111/bcp.15682

By:

Martínez‐Mardones, Francisco;
Benrimoj, Shalom I.;
Ahumada‐Canale, Antonio;
Plaza‐Plaza, Jose C.;
Garcia‐Cardenas, Victoria

Publication type:

Article

A case series of bacillus Calmette‐Guérin scar reactivation after administration of both mRNA and viral vector COVID‐19 vaccines.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2113, doi. 10.1111/bcp.15678

By:

van Balveren, Leontine;
van Puijenbroek, Eugène P.;
Davidson, Linda;
van Hunsel, Florence

Publication type:

Article

Evaluation of the inhibitory effects of itraconazole on letermovir.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2122, doi. 10.1111/bcp.15677

By:

McCrea, Jacqueline B.;
Menzel, Karsten;
Fancourt, Craig;
Witter, Rose;
Zhao, Tian;
Robbins, Jonathan A.;
Stoch, S. Aubrey;
Iwamoto, Marian

Publication type:

Article

Preventive effect of dexamethasone premedication on the development of infusion‐related reaction in breast cancer patients receiving trastuzumab.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2102, doi. 10.1111/bcp.15675

By:

Goto, Emi;
Hata, Takeo;
Nishihara, Masami;
Neo, Masashi;
Iwamoto, Mitsuhiko;
Kimura, Kosei;
Goto, Masahiro;
Rikitake, Yoshiyuki

Publication type:

Article

A phase I, single‐sequence, open‐label study to evaluate the drug–drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2160, doi. 10.1111/bcp.15664

By:

Li, Fengshan;
Lin, Hongda;
Feng, Shiyin;
Cai, Linrui;
Zhang, Lingli;
Feng, Sheng;
Liu, Xiaohong;
Chen, Zhuo;
Zou, Qin;
Wu, Yiwen;
Su, Xu;
Shen, Kai;
Yu, Qin

Publication type:

Article

A population pharmacokinetic–pharmacodynamic model evaluating efficacy of nalbuphine extended‐release in patients with prurigo nodularis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2088, doi. 10.1111/bcp.15663

By:

Eudy‐Byrne, Rena;
Riggs, Matthew;
Hawi, Amale;
Sciascia, Thomas;
Rohatagi, Shashank

Publication type:

Article

Optimizing adherence to allopurinol for gout: patients' perspectives.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1978, doi. 10.1111/bcp.15657

By:

Spragg, Jane C. J.;
Michael, Toni J. F.;
Aslani, Parisa;
Coleshill, Matthew J.;
Chan, Jian S.;
Day, Richard O.;
Stocker, Sophie L.

Publication type:

Article

An allopurinol adherence tool using plasma oxypurinol concentrations.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1956, doi. 10.1111/bcp.15516

By:

Smith‐Diaz, Natalia;
Stocker, Sophie L.;
Stamp, Lisa K.;
Dalbeth, Nicola;
Phipps‐Green, Amanda J.;
Merriman, Tony R.;
Wright, Daniel F. B.

Publication type:

Article

Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1965, doi. 10.1111/bcp.15515

By:

Fox, William S.;
Strydom, Natasha;
Imperial, Marjorie Z.;
Jarlsberg, Leah;
Savic, Radojka M.

Publication type:

Article

Estimation of adherence to medication treatment in presence of censoring.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1928, doi. 10.1111/bcp.15452

By:

Pasquier, Jérôme;
Schneider, Marie P.;
Locatelli, Isabella

Publication type:

Article

Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis‐inspired systematic review.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1996, doi. 10.1111/bcp.15418

By:

Hogervorst, Stijn;
Vervloet, Marcia;
Adriaanse, Marcel C.;
Zamboni, Karen;
Zullig, Leah L.;
Schoonmade, Linda;
Hugtenburg, Jacqueline G.;
van Dijk, Liset

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1911, doi. 10.1111/bcp.15402
Publication type:: Article

Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1918, doi. 10.1111/bcp.15375

By:

Dima, Alexandra L.;
Allemann, Samuel S.;
Dunbar‐Jacob, Jacqueline;
Hughes, Dyfrig A.;
Vrijens, Bernard;
Wilson, Ira B.

Publication type:

Article

A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2076, doi. 10.1111/bcp.15373

By:

Donneyong, Macarius M.;
Zhu, Yuxi;
Zhang, Pengyue;
Li, Yiting;
Hunold, Katherine M.;
Chiang, ChienWei;
Unroe, Kathleen;
Caterino, Jeffrey M.;
Li, Lang

Publication type:

Article

Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1992, doi. 10.1111/bcp.15325

By:

Schneider, Marie P.;
Burnier, Michel

Publication type:

Article

Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1938, doi. 10.1111/bcp.15318

By:

Jamshidi, Nazila;
Athavale, Akshay;
Tremonti, Christopher;
McDonald, Catherine;
Banukumar, Shanmugam;
Vazquez, Santiago;
Luquin, Natasha;
Santiago, Marina;
Murnion, Bridin

Publication type:

Article

How to handle a delayed or missed dose of edoxaban in patients with non‐valvular atrial fibrillation? A model‐informed remedial strategy.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2066, doi. 10.1111/bcp.15316

By:

Yin, Yi‐wei;
Liu, Xiao‐qin;
Gu, Jia‐qin;
Li, Zi‐ran;
Jiao, Zheng

Publication type:

Article

Major disparities in patient‐reported adherence compared to objective assessment of adherence using mass spectrometry: A prospective study in a tertiary‐referral hypertension clinic.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1948, doi. 10.1111/bcp.15292

By:

Curneen, James M. G.;
Rabbitt, Louise;
Browne, Darragh;
O'Donoghue, Darragh F.;
Alansari, Yousef;
Harhen, Brendan;
Ní Ghríofa, Ailbhe;
Ferguson, John;
McEvoy, John William;
Lappin, David;
Finn, David P.;
O'Shea, Paula M.;
Dennedy, Michael Conall

Publication type:

Article